RACHEL GRAY: Open Payments
NPI 1992043525 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 14 payments from 9 companies in 2025. Trend: 2023 $131 · 2024 $211 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Lilly USA, LLC | 3 | $53 |
| PFIZER INC. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Organon LLC | 1 | $25 |
| Abbott Laboratories | 1 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
| Medtronic, Inc. | 1 | $16 |
Products named: LEQVIO, MOUNJARO, PREVNAR 20, DUPIXENT, NEXPLANON, FREESTYLE LIBRE 3, YCANTH, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
